Abstract
Background
Proinflammatory cytokines play an important role in the establishment of arteriolosclerosis and kidney injury. Inflammatory cytokines are involved in the development of microvascular diabetic complications, including diabetic nephropathy (DN). Interleukin-19 (IL-19) has vital functions in many inflammatory processes and also can induce the angiogenesis of endothelial cells.
Objective
To investigate the role of IL-19 in the development of DN.
Patients and methods
A total of 112 participants were included and classified into four main groups: group I was the control group, which included 28 age-matched and sex-matched persons; group II included 28 patients with type 2 diabetes without nephropathy (normoalbuminuria); group III included 28 patients with type 2 diabetes with nephropathy (microalbuminuria); and group IV included 28 patient with type 2 diabetes with nephropathy (macroalbuminuria). All participants were subjected to complete blood count, complete urine analysis, fasting and random blood glucose, glycosylated hemoglobin (HbA1c), serum creatinine and urea, urinary albumin excretion rate (UAE), albumin-creatinine ratio (ACR), lipid profile, and serum IL-19 level assays.
Results
C-reactive protein (CRP) and serum IL-19 levels were significantly higher in diabetic patients compared with controls. IL-19 levels were significantly positively correlated with serum creatinine, ACR, UAE, HbA1c, and CRP. Multivariable logistic regression analysis showed that IL-19 levels were independently associated with patients with DN.
Conclusion
IL-19 levels were elevated in patients with DN and were positively correlated with ACR, UAE, HbA1c, and CRP. IL-19 may play an important role that contributes to the progression of DN.
Article PDF
Similar content being viewed by others
References
Fujita T, Ogihara N, Kamura Y, Satomura A, Fuke Y, Shimizu C, et al. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications. Acta Diabetol 2012; 49:111–117.
Lim A. KH. Diabetic nephropathy – complications and treatment. Int J Nephrol Renovasc Dis 2014; 7:361–381.
Bennett K, Aditya BS. An overview of diabetic nephropathy: epidemiology, pathophysiology and treatment. J Diabet Nurs 2015; 18:61–67.
Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ. Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) 2006; 11:226–231.
Hofmann SR, Rösen-Wolff A, Tsokos GC, Hedrich CM. Biological properties and regulation of IL-10 related cytokines and their contributionto autoimmune disease and tissue injury. Clin Immunol 2012; 143:116–127.
Ellison S, Gabunia K, Richards JM, Kelemen S, England R, Rudic D, et al. IL-19 reduces ligation-mediated neo intimal hyperplasia by reducing vascular smooth muscle cell activation. Am J Pathol 2014; 184:2134–2143.
Li L, Jiang XG, Hu JY, Yu ZQ, Xu JY, Liu F, et al. The association between interleukin-19 concentration and diabetic nephropathy. BMC Nephrol 2017; 18:65.
Zhenhua H. Diagnosis and treatment of diabetic nephropathy in type1 and type 2 diabetes patients. J Mol Biomark Diagn 2016; 7:295.
Martini S, Eichinger F, Nair V, Kretzler M. Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord 2008; 9:267–274.
Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diabetes Rep 2006; 6:463–468.
Yin Q, Zhai Q, Wang D, Hai J, Cao M, Wang J, et al. Investigation on the association between inerleukin-10 –592C/A, 819C/T and –1082A/G gene polymorphisms and development of diabetic nephrophathy. Int J Clin Exp Pathol 2015; 8:15216–15221.
Klessens CQ, Woutman TD, Veraar KA, Zandbergen M, Valk EJ, Rotmans JI, et al. An autopsy study suggests that diabetic nephropathy is under diagnosed. Kidney Int 2016; 90:149–156.
Freedman B, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007; 2:1306–1131.
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000; 404:787–790.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2044; 351:1296–1305.
Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetics Metab 2016; 26:254–264.
Arık HO, Yalcin AD, Gumuslu S, Genç GE, Turan A, Sanlioglu AD. Association of circulating sTRAIL and CRP with type 2 diabetic nephropathy and foot ulcers. Med Sci Monit 2013; 29:712–715.
Yamaoka-Tojo M, Tojo T, Masuda T, Machida Y, Kitano Y, Kurosawa T, et al. C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels 2003; 18:183–187.
Cuneo AA, Herrick D, Autieri MV. IL-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. J Mol Cell Cardiol 2010; 49:647–654.
Fujita H, Taniai H, Murayama H, Ohshiro H, Hayashi H, Sato S, et al. DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy. Endocr J 2014; 61:159–166.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elhefnawy, K.A., Salah, A.M. & Elsaid, H.H. The role of interleukin-19 in diabetic nephropathy. Egypt J Intern Med 31, 917–921 (2019). https://doi.org/10.4103/ejim.ejim_153_19
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_153_19